Clinical trial
Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to…
NCT00002174 · Louisiana State University Health Sciences Center in New Orleans, Other · Completed
Key facts
| NCT number | NCT00002174 |
|---|---|
| Title | Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients |
| Official title | Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients |
| Lead sponsor | Louisiana State University Health Sciences Center in New Orleans, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 20 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: